Sunil Agarwal, Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,041 shares at $52.68 ($54K) on 2016-07-21, disclosed to the SEC on 2016-07-21.
Scheduled sale ($54k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.55 | 392 | $20K | 36.7% |
| 2 | $52.68 | 649 | $34K | 63.3% |
| Total | $51.88 avg | 1,041 | $54K | 100% |
| Filing → |
| RARE | SELL | 2016-06-21 | $35K | — | Filing → |
| RARE | SELL | 2016-05-26 | $43K | — | Filing → |
| RARE | SELL | 2016-04-21 | $46K | — | Filing → |